+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Late toxicity after short course preoperative radiotherapy and total mesorectal excision for resectable rectal cancer



Late toxicity after short course preoperative radiotherapy and total mesorectal excision for resectable rectal cancer



Clinical Oncology ) 15(5): 233-236



The late toxicity of short-course preoperative radiotherapy (SCPRT) after total mesorectal excision (TME) in resectable rectal cancer has not been adequately documented. The acute toxicity in a series of 176 consecutive patients has been previously reported. In this study, the late toxicity in the same cohort is presented. Side-effects occurring more than 3 months after the start of SCPRT were graded using the EORTC/RTOG late radiation toxicity system. We performed multivariate analysis to identify associated factors. Of 176 patients, 15 died within 3 months of SCPRT and five patients were lost to follow-up. One hundred and fifty-six patients were assessable at a median follow-up interval of 41 months: severe (grade 3-4) toxicity was seen in 20 patients (13%), of which 13 were gastrointestinal (8%); three urological (2%); three thromboembolic (2%), and one musculoskeletal (1%). On multivariate analysis, abdomino-perineal (AP) resection (P < 0.02) was associated with a lower risk of grade 3-4 toxicity. In this retrospective study, the rate of late grade 3-4 toxicity after SCPRT and TME was 13%. Although AP resection seems to be associated with a lower incidence of late toxicity, this could be counterbalanced by the impact of a stoma on quality of life. These factors should be considered when determining the optimal management of resectable rectal cancers.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 049455293

Download citation: RISBibTeXText

PMID: 12924451

DOI: 10.1016/s0936-6555(03)00118-3


Related references

Clinical results and toxicity for short-course preoperative radiotherapy and total mesorectal excision in rectal cancer patients. Journal of Radiation Research 56(1): 169-176, 2015

Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer. New England Journal of Medicine 345(9): 638-646, 2001

Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer. Strahlentherapie und Onkologie 177(12): 682-684, 2002

Canadian Association of General Surgeons Evidence Based Reviews in Surgery. 5. Need for preoperative radiation in rectal cancer. Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer. Canadian Journal of Surgery. Journal Canadien de Chirurgie 46(1): 54-56, 2003

Efficacy of preoperative radiotherapy combined with total mesorectal excision in the treatment of locally resectable rectal cancer: a systematic review. Zhonghua Wei Chang Wai Ke Za Zhi 13(3): 197-201, 2010

Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer: 12-year follow-up of the multicentre, randomised controlled TME trial. Lancet. Oncology 12(6): 575-582, 2011

Total mesorectal excision with and without preoperative radiotherapy for patients with resectable rectal cancer: The multicentre, randomised controlled TME trial 12-year follow-up. Strahlentherapie und Onkologie 188(7): 634-635, 2012

Late side effects of short-course preoperative radiotherapy combined with total mesorectal excision for rectal cancer: increased bowel dysfunction in irradiated patients--a Dutch colorectal cancer group study. Journal of Clinical Oncology 23(25): 6199-6206, 2005

Categorization of major and minor complications in the treatment of patients with resectable rectal cancer using short-term pre-operative radiotherapy and total mesorectal excision: a Delphi round. Colorectal Disease 8(4): 302-308, 2006

Bowel function 14 years after preoperative short-course radiotherapy and total mesorectal excision for rectal cancer: report of a multicenter randomized trial. Clinical Colorectal Cancer 14(2): 106-114, 2016

Outcome in patients with resectable locally recurrent rectal cancer after total mesorectal excision with and without previous neoadjuvant radiotherapy for the primary rectal tumor. Annals of Surgical Oncology 21(2): 520-526, 2014

Health-related quality of life 14 years after preoperative short-term radiotherapy and total mesorectal excision for rectal cancer: report of a multicenter randomised trial. European Journal of Cancer 50(14): 2390-2398, 2015

Late effects following total mesorectal excision and short course preoperative radiotherapy. British Journal of Cancer 88(Supplement 1): S20, July, 2003

Acute side effects and complications after short-term preoperative radiotherapy combined with total mesorectal excision in primary rectal cancer: report of a multicenter randomized trial. Journal of Clinical Oncology 20(3): 817-825, 2002

Preoperative radiotherapy combined with intraoperative radiotherapy improve results of total mesorectal excision in patients with T3 rectal cancer. Diseases of the Colon and Rectum 47(2): 170-179, 2004